Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Northcott

Showing results (81-90 of 223) with videos related to

Pageof 23
Sort By:
Cancer Research|October 5, 2013
MyoD is a tumor suppressor gene in medulloblastomaJoyoti Dey, Adrian M Dubuc, Kyle D Pedro, et al.
Endocrinology|February 23, 2012
The development of hypertension and hyperaldosteronism in a rodent model of life-long obesityCarrie A Northcott, Greg D Fink, Hannah Garver, et al.
Nature Reviews. Cancer|November 24, 2012
Medulloblastomics: the end of the beginningPaul A Northcott, David T W Jones, Marcel Kool, et al.
Nature Communications|June 5, 2019
Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastomaVictor Maximov, Zhihong Chen, Yun Wei, et al.
Clinical and Translational Science|August 10, 2020
Fit-for-Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker ExperienceAlan Godfrey, Benjamin Vandendriessche, Jessie P Bakker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Medulloblastoma comprises four distinct molecular variantsPaul A Northcott, Andrey Korshunov, Hendrik Witt, et al.
Nature Reviews. Disease Primers|February 16, 2019
MedulloblastomaPaul A Northcott, Giles W Robinson, Christian P Kratz, et al.
Cancer Research|April 9, 2009
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursorsPaul A Northcott, Africa Fernandez-L, John P Hagan, et al.
Cancer Cell|May 26, 2012
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYCFredrik J Swartling, Vasil Savov, Anders I Persson, et al.
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
Pageof 23

Showing results (81-90 of 223) with videos related to

Sort By:
Pageof 23
Cancer Research|October 5, 2013
MyoD is a tumor suppressor gene in medulloblastomaJoyoti Dey, Adrian M Dubuc, Kyle D Pedro, et al.
Endocrinology|February 23, 2012
The development of hypertension and hyperaldosteronism in a rodent model of life-long obesityCarrie A Northcott, Greg D Fink, Hannah Garver, et al.
Nature Reviews. Cancer|November 24, 2012
Medulloblastomics: the end of the beginningPaul A Northcott, David T W Jones, Marcel Kool, et al.
Nature Communications|June 5, 2019
Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastomaVictor Maximov, Zhihong Chen, Yun Wei, et al.
Clinical and Translational Science|August 10, 2020
Fit-for-Purpose Biometric Monitoring Technologies: Leveraging the Laboratory Biomarker ExperienceAlan Godfrey, Benjamin Vandendriessche, Jessie P Bakker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Medulloblastoma comprises four distinct molecular variantsPaul A Northcott, Andrey Korshunov, Hendrik Witt, et al.
Nature Reviews. Disease Primers|February 16, 2019
MedulloblastomaPaul A Northcott, Giles W Robinson, Christian P Kratz, et al.
Cancer Research|April 9, 2009
The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursorsPaul A Northcott, Africa Fernandez-L, John P Hagan, et al.
Cancer Cell|May 26, 2012
Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYCFredrik J Swartling, Vasil Savov, Anders I Persson, et al.
Molecular Cancer Therapeutics|June 16, 2022
Combination of Ribociclib and Gemcitabine for the Treatment of MedulloblastomaAllison Pribnow, Barbara Jonchere, Jingjing Liu, et al.
Pageof 23